Prevaccination antibody screening and immunization program for healthcare personnel against measles, Mumps, Rubella, And varicella in a japanese tertiary care hospital

Tohoku Journal of Experimental Medicine

Volumn 234, Issue 2, 2014, Pages 111-116

  Kanamori, Hajime ^a,b,c   Tokuda, Koichi ^a,b   Ikeda, Shinobu ^b   Endo, Shiro ^a,b   Ishizawa, Chiyuki ^b   Hirai, Yukari ^b   Takahashi, Masami ^b   Aoyagi, Tetsuji ^a   Hatta, Masumitsu ^a   Gu, Yoshiaki ^a   Yano, Hisakazu ^a   Weber, David J ^c   Kaku, Mitsuo ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Immunization; Measles; Mumps; Rubella; Varicella

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; IMMUNOGLOBULIN G; CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; VIRUS ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBODY SCREENING; ARTICLE; CHICKENPOX; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL MANAGEMENT; HEALTH PROGRAM; HUMAN; IMMUNE STATUS; IMMUNIZATION; INFECTION CONTROL; INFECTION SENSITIVITY; JAPANESE (PEOPLE); MALE; MEASLES; MEDICAL HISTORY; MUMPS; OCCUPATIONAL SAFETY; RUBELLA; SEROLOGY; SEROPREVALENCE; TERTIARY CARE CENTER; VERY ELDERLY; BLOOD; EPIDEMIOLOGY; HEALTH CARE PERSONNEL; JAPAN; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; VACCINATION; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PERSONNEL; HUMANS; IMMUNIZATION PROGRAMS; JAPAN; MALE; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; MUMPS; RUBELLA; SEROEPIDEMIOLOGIC STUDIES; TERTIARY CARE CENTERS; VACCINATION; YOUNG ADULT;

EID: 84907510497     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.234.111     Document Type: Article

References (18)

1. Almuneef, M.A., Memish Z.A., Balkhy H.H., Otaibi B. & Helmi M. (2006) Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect. Control Hosp. Epidemiol., 27, 1178-1183.
2. Asari, S., Deguchi M., Tahara K., Taniike M., Toyokawa M., Nishi I., Watanabe M., Iwatani Y. & Makimoto K. (2003) Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am. J. Infect. Control, 31, 157-162.
3. Celikbas, A., Ergonul O., Aksaray S., Tuygun N., Esener H., Tanir G., Eren S., Baykam N., Guvener E. & Dokuzoguz B. (2006) Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Am. J. Infect. Control, 34, 583-587.
4. Centers for Disease Control and Prevention (CDC) (1996) Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep., 45 (RR-12), 1-35.
5. Centers for Disease Control and Prevention (CDC) (2008) Progress toward measles elimination: Japan, 1999-2008. MMWR Morb. Mortal. Wkly. Rep., 57, 1049-1052.
6. Centers for Disease Control and Prevention (CDC) (2011) Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep., 60 (RR-7), 1-45.
7. Centers for Disease Control and Prevention (CDC) (2013) Nationwide rubella epidemic: Japan, 2013. MMWR Morb. Mortal. Wkly. Rep., 62, 457-462.
8. Fedeli, U., Zanetti C. & Saia B. (2002) Susceptibility of healthcare workers to measles, mumps rubella and varicella. J. Hosp. Infect., 51, 133-135.
9. Hatakeyama, S., Moriya K., Itoyama S., Nukui Y., Uchida M., Shintani Y., Morisawa Y. & Kimura S. (2004) Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan. Infect. Control Hosp. Epidemiol., 25, 591-594.
10. Japanese Society for Infection Prevention and Control (2009) Vaccination guidelines for nosocomial infection control (in Japanese). http://www.kankyokansen.org/modules/publication/index.php?content_id=4. [Accessed: August 1, 2014].
11. Maltezou, H.C., Wicker S., Borg M., Heininger U., Puro V., Theodoridou M. & Poland G.A. (2011) Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine, 29, 9557-9562.
12. McLean, H.Q., Fiebelkorn A.P., Temte J.L. & Wallace G.S.; Centers for Disease Control and Prevention (2013) Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep., 62 (RR-04), 1-34.
13. National Institute of Infectious Diseases (2013) Infectious Agents Surveillance Report (IASR). http://www.nih.go.jp/niid/en/iasr-e.html [Accessed: January 14, 2014].
14. Plans, P. (2013) New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population. Eur. J. Clin. Microbiol. Infect. Dis., 32, 961-966.
15. Public Health England (2013) Immunisation against infectious disease. https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book [Accessed: March 27, 2014].
16. Trevisan, A., Frasson C., Morandin M., Beggio M., Bruno A., Davanzo E., Di Marco L., Simioni L. & Amato G. (2007) Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease. Infect. Control Hosp. Epidemiol., 28, 564-569.
17. Weber, D.J., Consoli S., Sickbert-Bennett E., Miller M.B. & Rutala W.A. (2010) Susceptibility to measles, mumps, and rubella in newly hired (2006-2008) healthcare workers born before 1957. Infect. Control Hosp. Epidemiol., 31, 655-657.
18. World Health Organization (2014) Immunization, Vaccines and Biologicals. Policy recommendations. http://www.who.int/immunization/policy/en/ [Accessed: August 1, 2014].